Loading clinical trials...
Loading clinical trials...
Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy - a Double Blind Randomized Control Trial
Conditions
Interventions
Vaginal progesterone
Placebo
Locations
1
Canada
Mount Sinai Hospital
Toronto, Ontario, Canada
Start Date
December 1, 2016
Primary Completion Date
December 1, 2020
Last Updated
March 20, 2024
NCT07118891
NCT06798571
NCT07218445
NCT07472881
NCT06900374
NCT05188027
Lead Sponsor
Mount Sinai Hospital, Canada
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions